San Francisco, CA. July 10, 2023 – Kaliber Labs is pleased to announce the appointment of Tom Borg as Vice President of Growth. With a distinguished career at Johnson & Johnson, including serving as the MedTech Director of Global Market Development for Sports Medicine & Shoulder Arthroplasty, Mr. Borg brings a wealth of experience in driving commercial excellence and global market expansions for medical devices. His expertise will be instrumental in advancing Kaliber's expansion initiatives.
“We are honored to have Tom Borg on board," stated Kaliber CEO Ray Rahman. “As we introduce surgical AI to orthopedic practices worldwide, his understanding of the global medical device marketplace will accelerate our growth and strengthen our healthcare partnerships. He joins at a pivotal moment and will bring additional depth of experience to Kaliber’s leadership team."
During his remarkable 27-year tenure at Johnson & Johnson, Mr. Borg served as the MedTech Director of Global Market Development for Sports Medicine & Shoulder Arthroplasty, demonstrating his visionary approach as a market-maker for groundbreaking medical devices. His efforts were instrumental in driving revenue growth, demonstrated by an increase in J&J China's Sports Medicine business from its inception to over $100 million. With extensive experience in building market exposure across the US, Asia, Latin America, South Africa, and Europe, he has forged invaluable relationships with esteemed global physician society groups, including ISAKOS, AO, and IFOSMA.
“Kaliber’s surgical solutions are poised to transform orthopedic surgery and patient care in ways that are very exciting,” said Borg. “Recognizing that the company is expanding frontiers that can benefit patients considerably, I look forward to helping Kaliber forge a path that actualizes the value of their surgeon-trained AI.”
Tom Borg is the newest addition to Kaliber's distinguished leadership, which boasts extensive expertise in artificial intelligence, medicine, data engineering, and medical devices.